ECYT
Endocyte, Inc. Common Stock
ECYT
ECYT
Delisted
ECYT was delisted on the 20th of December, 2018.
98 hedge funds and large institutions have $85.5M invested in Endocyte, Inc. Common Stock in 2015 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 38 increasing their positions, 25 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less capital invested
Capital invested by funds: $ → $
27% less call options, than puts
Call options by funds: $936K | Put options by funds: $1.28M
Holders
98
Holding in Top 10
–
Calls
$936K
Puts
$1.28M
Top Buyers
| 1 | +$580K | |
| 2 | +$521K | |
| 3 | +$409K | |
| 4 |
EGA
Eagle Global Advisors
Houston,
Texas
|
+$262K |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$260K |
Top Sellers
| 1 | -$5.72M | |
| 2 | -$842K | |
| 3 | -$540K | |
| 4 |
AQR Capital Management
Greenwich,
Connecticut
|
-$453K |
| 5 |
TAM
Tocqueville Asset Management
New York
|
-$376K |